Unknown

Dataset Information

Rectal indomethacin and diclofenac are equally efficient in preventing pancreatitis following endoscopic retrograde cholangiopancreatography in average-risk patients.


ABSTRACT: Rectal indomethacin and diclofenac are promising drugs for prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). However, their prophylactic effect on PEP in average-risk patients remains controversial. We performed a systematic review and meta-analysis to assess the efficacy and safety of rectal indomethacin and diclofenac in average-risk patients, and to indirectly compare the prophylactic effect of the two drugs. A comprehensive search of the PubMed, EMBASE, and Cochrane Library databases was performed to identify randomized controlled trials (RCTs) on rectal indomethacin or diclofenac for prophylaxis against PEP. Fixed- and random-effects models weighted by the Mantel-Haenszel method were used for direct comparisons. The adjusted indirect treatmen

SUBMITTER: Yu S 

PROVIDER: S-EPMC8485396 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature